<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Molecular Microbiology (2010) 77(3), 658&#226;&#8364;&#8220;671 &#228;&#352;?                                                           doi:10.1111/j.1365-2958.2010.07236.x <br />                                                                                                           First published online 15 June 2010 <br />  <br />  <br />  <br /> Trypanosoma brucei pteridine reductase 1 essential for <br /> <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span>survival</span> vitro virulence mice                                          mmi_7236 658..671 <br />  <br />  <br />  <br />  <br /> Natasha Sienkiewicz, Han B. Ong                                aromatic amino acid hydroxylases, glyceryl ether <br /> Alan H. Fairlamb*                                                  monooxygenases NO synthases (Thony et al., 2000; <br /> Division Biological Chemistry &amp; Drug Discovery,                 Werner-Felmayer et al., 2002; Schmidt Alp, 2007; <br /> College Life Sciences, University Dundee,                    Watschinger et al., 2009). In humans, H4B synthe- <br /> Dundee, UK.                                                        sized novo GTP salvaged dihydrobiop- <br />                                                                    terin (H2B) NADPH-dependent dihydrofolate <br />                                                                    reductase (DHFR, EC 1.5.13) (Nichol et al., 1983) or <br /> Summary                                                            regenerated quinonoid dihydrobiopterin, by- <br /> Gene <span id='am-237' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-238' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-263' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-295' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span>knockout</span> knockdown methods used                   product hydroxylation reactions, NAD(P)H- <br /> examine essentiality pteridine reductase (PTR1)              dependent 6,7-dihydropteridine reductase (DHPR; EC <br /> pterin metabolism African trypanosome.                      1.5.1.34) (Armarego et al., 1983). <br /> Attempts generate PTR1 <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> blood-                      In contrast humans, biological genomic data <br /> stream form Trypanosoma brucei proved unsuccess-                   indicate trypanosomatids lack ability synthesize <br /> ful; despite integration drug selectable markers             pterins novo, totally dependent salvage of <br /> the target locus, gene PTR1 retained            extracellular pterins growth (Bello et al., 1994; Cun- <br /> at locus genome.                      ningham Beverley, 2001; Berriman et al., 2005; Ivens <br /> However, <span id='am-393' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-394' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-396' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-397' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-398' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-399' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-400' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-402' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-403' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-404' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-405' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-406' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-407' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-408' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-409' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-410' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-411' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-412' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-413' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-414' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-416' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-417' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-418' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-419' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-420' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-421' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-422' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-423' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-424' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-425' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-427' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-428' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-429' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-430' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-431' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-432' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-433' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-435' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-436' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-437' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-439' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-440' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-441' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-445' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-446' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-447' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-448' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-449' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-450' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-451' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-452' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-453' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-454' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-458' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-459' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-460' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-461' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-462' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-463' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-466' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-467' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-468' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-470' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi) resulted com-                  et al., 2005). The essential requirement pterins was <br /> plete knockdown endogenous protein 48 h,                  initially discovered Crithidia fasciculata grown a <br /> followed cell death 4 days. This lethal pheno-            defined medium containing low amounts folate (Kidder <br /> type reversed expression enzymatically                   Dutta, 1958; Kaufman, 1963); subsequent <br /> active Leishmania major PTR1 RNAi lines (oeRNAi)                understanding uptake, salvage functions of <br /> or addition tetrahydrobiopterin cultures. Loss            pterins trypanosomatids come principally <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> of PTR1 associated gross morphological                    studies Beverley Ouellette groups (Nare et al., <br /> changes defect cytokinesis, resulting               1997; Ouellette et al., 2002). In Leishmania spp., biopterin <br /> cells multiple nuclei kinetoplasts,            taken medium biopterin transporter <br /> multiple detached flagella. Electron microscopy               BT1 (Kundig et al., 1999; Lemley et al., 1999) then <br /> revealed increased numbers glycosomes,                    sequentially reduced H2B H4B pteridine reduc- <br /> immunofluorescence microscopy showed increased                     tase 1 (PTR1; EC 1.5.1.33) (Bello et al., 1994). Previous <br /> and diffuse staining glycosomal matrix                    studies Leishmania ptr1 - mutants suggested pres- <br /> enzymes, indicative mis-localisation cytosol.            ence residual pteridine reductase activity, provision- <br /> Mis-localisation confirmed digitonin fraction-              ally assigned PTR2. This activity considered <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br /> ation experiments. RNAi cell lines markedly              quinonoid dihydropteridine reductase the <br /> virulent wild-type parasites mice virulence            identity PTR2 remains unknown (Lye et al., 2002). <br /> was restored oeRNAi line. Thus, PTR1               Some kinetic, inhibitor structural properties have <br /> drug target human African trypanosomiasis.                     reported PTR1 Leishmania major (Luba <br />                                                                    et al., 1998; Gourley et al., 2001; Schuttelkopf et al., <br />                                                                    2005), Trypanosoma cruzi (Schormann et al., 2005) and <br /> Introduction                                                       Trypanosoma brucei (Dawson et al., 2006; Mpamhanga <br />                                                                    et al., 2009; Shanks et al., 2010). <span id='am-315' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-316' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-318' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-329' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-337' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-349' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-352' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-359' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-361' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-363' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-365' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-366' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-373' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-376' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span>Gene knockout</span> studies <br /> Tetrahydrobiopterin (H4B) essential cofactor for <br />                                                                    L. major demonstrated PTR1 essential for <br /> various hydroxylation reactions catalysed enzymes <br />                                                                    growth insect promastigote stage parasite, <br /> Accepted 20 May, 2010. *For correspondence. E-mail a.h.fairlamb@   growth ptr1 - null mutants restored with <br /> dundee.ac.uk; Tel. (+44) 1382 385155; Fax (+44) 1382 385542.       H2B H4B, dihydro- tetrahydrofolate (Bello <br /> Re-use article permitted accordance Terms <br /> and Conditions set http://www3.interscience.wiley.com/      et al., 1994). These mutants showed increased formation <br /> authorresources/onlineopen.html                                    mammalian-infective metacyclic promastigote forms in <br /> &#194;&#169; 2010 Blackwell Publishing Ltd <br />                                                                                                    Essentiality pteridine reductase 1 659 <br />  <br /> stationary phase cultures consequently gave larger             drug selection hygromycin puromycin, <br /> lesions injected mice (Cunningham et al.,                essentially described (Sienkiewicz et al., 2008). SKO <br /> 2001). This indicates ptr1 - amastigotes viable        lines (PTR1/ptr1::HYG [SKOHYG] PTR1/ptr1::PAC <br /> vivo, presumably abundant H4B host macroph-              [SKOPAC]) subjected second round trans- <br /> ages consequently PTR1 drug target            fection knockout construct selected for <br /> its L. major.                                               resistance drugs. Despite obtaining double drug- <br />    PTR1 secondary role metabolism able           resistant trypanosomes numerous independent experi- <br /> to reduce dihydrofolate tetrahydrofolate. Amplification         ments, unable obtain clones both <br /> of PTR1 Leishmania spp. mecha-            copies PTR1 deleted. Southern blotting con- <br /> nisms parasites acquire resistance antifolates         firmed integration drug-resistant genes had <br /> such methotrexate (Callahan Beverley, 1992;                 occurred correct locus, associated <br /> Papadopoulou et al., 1992; Bello et al., 1994)           retention additional copy PTR1 the <br /> acting by-pass mechanism sequestering             locus genome (see Fig. S1). In <br /> DHFR inhibitors. Recent studies demonstrated               virulent strains leishmania, behaviour typical of <br /> intriguing link unconjugated pterins oxidative         essential gene (Cruz et al., 1993), been <br /> susceptibility variety Leishmania PTR1 knockout            reported African trypanosome. However, an <br /> and overexpressing cell lines (Moreira et al., 2009; Nare          increase chromosomal copy number reported <br /> et al., 2009). However, mechanism involved              trypanosomes selected resistance mycophenolic <br /> clear; known pterins additional         acid, inhibitor IMP dehydrogenase (Wilson et al., <br /> essential functions parasites.                            1994). Attempts generate conditional double knockout <br />    In contrast Leishmania spp. virtually known       cell lines introducing ectopic copy PTR1 <br /> about pterin metabolism African trypanosomes, para-             (pLew100_TbPTR1) tetracycline control also <br /> sites occupy completely different (extracellular) envi-     unsuccessful. <br /> ronment mammalian host. In study use                   In light results, inducible RNA interference <br /> genetic methods examine role PTR1 blood               (RNAi) studies using p2T7TiTAblue were <br /> stream form T. brucei respect essentiality vitro        undertaken deplete cells PTR1 (Alibu et al., 2005). <br /> and infectivity vivo. Our findings suggest reduced         For disruption PTR1 function, 403 bp region was <br /> pterins required glycosome flagellar biogenesis        ligated p2T7TiTAblue vector linearized con- <br /> and loss PTR1 activity compensated           struct transfected WT cells electroporation. Cells <br /> by reduced pterins plasma extracellular fluids. Thus,       integrated construct rDNA loci by <br /> unlike L. major, PTR1 potential drug target            homologous recombination obtained selection <br /> African trypanosome reference DHFR.                     hygromycin cloned. Generation the <br />                                                                    correct RNAi clones confirmed Southern analysis <br />                                                                    (data shown), tetracycline added cell <br /> Results                                                            cultures initiate expression PTR1-specific <br />                                                                    double-stranded RNA. The average cumulative growth <br /> Genotypic phenotypic analysis TbPTR1 <br />                                                                    different freshly derived clones illustrated in <br /> knockdown parasites <br />                                                                    Fig. 1A. In absence inducer cells grew at <br /> To assess essentiality PTR1, classical gene                 essentially rate WT cells. However, following <br /> replacement methods undertaken try produce            induction PTR1 dsRNA, growth ceased 1 day, <br /> PTR1 null cell line bloodstream trypanosomes. Consis-           followed decline cell numbers motile <br /> tent genome sequence data strain 927 (Berriman            parasites visible 4 days. Levels PTR1 protein <br /> et al., 2005), Southern blot analysis confirmed PTR1          diminished compared WT non-induced RNAi <br /> is single copy haploid genome &#226;&#8364;&#732;single marker&#226;&#8364;&#8482;           lines (Fig. 1A, inset) compared immunoglobulin <br /> bloodstream T. brucei 427 used studies (data          heavy-chain-binding protein (BiP) used loading <br /> shown). This organism, subsequently referred wild-           control. Densitometry PTR1 band relative BiP <br /> type (WT), constitutively expresses T7 RNA polymerase              control band indicated non-induced RNAi line had <br /> and tetracycline repressor protein, used         50% WT protein levels; decreased 9% <br /> express RNA constructs control tetra-           24 h RNAi induction detectable <br /> cycline (Wirtz et al., 1999). Replacement copy           48 h. This RNAi <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> unstable; the <br /> PTR1 generate single knockout (SKO)                  tetracycline-induction repeated 2&#226;&#8364;&#8220;3 <br /> readily achieved transfection construct contain-         weeks culture, cells showed growth defect <br /> ing drug resistance gene (either HYG PAC) flanked             knockdown PTR1, brief cytostasis followed <br /> by 5&#226;&#8364;&#178;- 3&#226;&#8364;&#178;-untranslated regions PTR1, followed           normal growth (Fig. S2). To confirm cidal effect <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  660 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br />  <br />  <br />  <br /> Fig. 1. The effect RNAi-dependent depletion PTR1 growth presence absence tetrahydrobiopterin. <br /> A. Effect RNAi cell growth. Four independent RNAi clones analysed growth defects following induction tetracycline the <br /> absence tetrahydrobiopterin. WT (open circles) RNAi cells (non-induced cells &#226;&#8364;&#8220; open squares induced cells &#226;&#8364;&#8220; closed squares) were <br /> seeded 1 &#194;&#165; 104 cells ml-1 growth determined 2 week period. WT, non-induced induced cells (1 &#194;&#165; 106 cells lane) <br /> were harvested 0 (non-induced), 24 h 48 h (induced) processed Western blot analysis. The blot sequentially probed with <br /> anti-TbPTR1 (inset, lower panel) anti-TbBIP (inset, upper panel) loading control. <br /> B. Effect tetrahydrobiopterin cell growth. WT cells freshly derived RNAi clone seeded FDM HMI9-T supplemented <br /> with 10 mM tetrahydrobiopterin 1 &#194;&#165; 104 cells ml-1 growth monitored 1 week. Symbols: WT (open circle; additions), <br /> non-induced RNAi cells (closed circles) tetracycline-induced cells plus minus tetrahydrobiopterin (closed open squares <br /> respectively). Data shown FDM only; HMI9-T shows essentially effect. <br />  <br />  <br /> of RNAi loss PTR1 activity, effect                  identity. Thus, LmPTR1 mRNA suscep- <br /> supplementation H4B examined freshly                       tible degradation, assembly RNA-induced <br /> derived clone (Fig. 1B). Addition 10 mM H4B RNAi-                  silencing complex requires formation 20&#226;&#8364;&#8220;26-mer <br /> induced cultures abolished lethal growth phenotype.                  double-stranded RNA (Ullu et al., 2004). Indeed, following <br />    Additional evidence essential requirement                  tetracycline induction, oeRNAi cells showed sign any <br /> PTR1 activity obtained introducing inducible                   growth defect whatsoever (Fig. 2A). Western blotting with <br /> overexpressing ectopic copy L. major PTR1                    antisera raised recombinant T. brucei PTR1 <br /> WT line (oeWT) prior generation TbPTR1 RNAi lines                  showed TbPTR1 expression undetectable follow- <br /> (oeRNAi). Due high GC content L. major gene,               ing induction (Fig. 2B; TbPTR1 ~30 kDa 55 kDa <br /> the sequence identity T. brucei RNAi construct               cross-reacting band serves internal loading control). <br /> less 50%, 13 nucleotide stretches                 In contrast, Western blotting second antiserum <br />  <br />                                                                                               Fig. 2. Rescue RNAi growth defect by <br />                                                                                               expression LmPTR1. <br />                                                                                               A. Cumulative growth WT (open circles) <br />                                                                                               non-induced oeRNAi cells (open inverted <br />                                                                                               triangles) tetracycline-induced oeRNAi <br />                                                                                               cells (closed triangles). <br />                                                                                               B. Western blot analysis demonstrating <br />                                                                                               knockdown TbPTR1 oeRNAi cells. <br />                                                                                               Non-induced (-) 48 h tetracycline induced <br />                                                                                               (+) cells probed sequentially with <br />                                                                                               anti-TbPTR1 anti-LmPTR1. A 55 kDa <br />                                                                                               non-specific band detected with <br />                                                                                               anti-TbPTR1, effect the <br />                                                                                               knockdown PTR1 serves internal <br />                                                                                               loading control (top panel), LmPTR1 is <br />                                                                                               present (bottom panel). <br />  <br />  <br />  <br />  <br />                                                                   &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />                                                                                                           Essentiality pteridine reductase 1 661 <br />  <br />                                                                      initial lag growth compared WT (Fig. 1B). Six of <br />                                                                      10 mice treated doxycycline failed develop para- <br />                                                                      sitaemia survived 30 days. Infection with <br />                                                                      oe <br />                                                                        RNAi cells (with doxycycline) restored the <br />                                                                      virulence phenotype WT cells. <br />  <br />  <br />                                                                      Morphological changes associated PTR1 depletion <br />  <br />                                                                      Severe morphological abnormalities observed in <br />                                                                      bloodstream trypanosomes light electron micros- <br />                                                                      copy prior cell death. After induction RNAi for <br />                                                                      24&#226;&#8364;&#8220;48 h, cells showed reduced motility, fatten- <br />                                                                      ing cell body shortening flagellum com- <br />                                                                      pared control (non-induced) samples. After 72 h, <br />                                                                      Giemsa-stained preparations showed gross distension of <br />                                                                      cell body multiple nuclei, kinetoplasts and <br /> Fig. 3. PTR1 enzyme activity WT transgenic T. brucei.         flagella. <br /> Cell lysates assayed PTR1 activity various protein          To provide insight changes cell cycle <br /> concentrations described materials methods. WT,        progression, DAPI-stained cells analysed deter- <br /> open circles; SKO, closed circles; oeRNAi minus tetracycline, open <br /> squares; oeRNAi plus tetracycline, closed squares.                   proportion cells nucleus (N) <br />                                                                      kinetoplast (K) control, non-induced and <br />                                                                      tetracycline induced populations (Fig. 5). Non-induced <br /> specific L. major PTR1 shows opposite effect.                 samples predominately 1K1N (92%), tetra- <br /> LmPTR1 visible ~30 kDa band non-induced                   cycline induction caused dramatic time-dependent <br /> (due leaky nature promoter pLew82) which <br /> increases following induction. PTR1 activity mea- <br /> sured cell lysates validate results. As shown in <br /> Fig. 3, PTR1 activity proportional protein concentra- <br /> tion cell line. WT cells specific activity of <br /> 22.9 &#226;&#171;&#190; 1.9 nmol min mg-1 decreased to <br /> 8.0 &#226;&#171;&#190; 0.2 nmol min mg-1 SKO line, this <br /> increases 2.5- 10-fold RNA lines overexpressing <br /> LmPTR1 absence presence inducer <br /> (58.1 &#226;&#171;&#190; 9.3 231 &#226;&#171;&#190; 19 nmol min mg-1 respectively). <br /> These results demonstrate LmPTR1 enzymatically <br /> active expressed T. brucei able rescue <br /> the lethal RNAi phenotype. <br />    Infectivity studies undertaken mice examine <br /> the virulence RNAi oeRNAi transgenic <br /> trypanosomes. Wild-type non-induced transgenic <br /> cells inoculated paired groups mice, where <br /> one pair received doxycycline drinking water. <br /> Parasitaemia monitored intervals 30 days; <br /> animals achieving parasitaemia greater 108 trypa- <br /> nosomes millilitre euthanized previous <br /> studies established levels consis- <br /> tently lethal 24 h. Mice infected 105 <br /> WT cells unable survive longer 3&#226;&#8364;&#8220;4 days                 Fig. 4. Virulence phenotype PTR1 mutants mice. Groups of <br /> (Fig. 4), mice infected RNAi cells survived             mice infected WT, non-induced cells RNAi and <br />                                                                      oe <br />                                                                        RNAi cells parasitaemia monitored intervals 30 day <br /> for longer regardless doxycycline treatment. The             period. The Kaplan-Meier survival graph shows aggregated <br /> reduced virulence observed minus doxycycline                  results independent experiments. Symbols: WT infection, no <br /> group probably leaky transcription p2T7            doxycycline (black dashed line); RNAi infection, doxycycline <br />                                                                      (blue solid line); RNAi infection plus doxycycline (red solid line); <br /> promoter, lowers baseline expression PTR1               oe <br />                                                                        RNAi infection, doxycycline (red dashed line); oeRNAi infection <br /> (Fig. 1A) instances associated                doxycycline (black dashed line, identical WT infection). <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  662 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br />                                                                                        Fig. 5. PTR1 depletion results changes to <br />                                                                                        cell cycle progression. Microscopic analysis of <br />                                                                                        DAPI stained RNAi cells non-induced (0 h) <br />                                                                                        induced (24, 48 72 h) populations <br />                                                                                        analysed determine proportion of <br />                                                                                        trypanosomes different numbers of <br />                                                                                        kinetoplasts (K) nuclei (N). Percentage <br />                                                                                        bar chart depicts changes K/N content <br />                                                                                        cell tetracycline induction RNAi. <br />                                                                                        Approximately 300 parasites population <br />                                                                                        analysed (n = 2, &#226;&#171;&#190; SD): non-induced <br />                                                                                        control (black bars); 24 h induction (dark grey <br />                                                                                        bars); 48 h induction (light grey bars) and <br />                                                                                        72 h induction (white bars). <br />  <br />  <br />  <br />  <br /> decrease number 1K1N trypanosomes (28%                 ing membrane (Fig. 6D, arrowheads). Multiple entangled <br /> 72 h) corresponding increase cells containing             flagella clearly identified SEM DAPI- <br /> either multiple kinetoplasts plus multiple nuclei (MKMN)         stained image (Fig. 6E F respectively). Phase- <br /> anucleated zoids (1K0N). The number cells               contrast light microscopy wet preparations showed that <br /> kinetoplasts nucleus (2K1N) increased threefold             grossly abnormal parasites viable, mul- <br /> from 6% 19% 48 h induction, decreasing 8%            tiple flagella moving uncoordinated fashion with <br /> at 72 h. 2K2N did vary markedly                  detached flagella instances radiating the <br /> time course. These results suggest cells              central body directions. There consider- <br /> undergo rounds mitosis, cytokinesis.             able disruption parasite surface appears <br />    Ultra-structural surface alterations examined           membrane disorganization deterioration. The <br /> by transmission electron microscopy (TEM) scanning              changes highlighted surface probably indi- <br /> electron microscopy (SEM) (Fig. 6). The obvious                cation stages RNAi effect cells that <br /> aberrant feature present TEM sections RNAi-           close death, seen central parasite <br /> induced cells increased number membrane                   Fig. 6D. <br /> bound electron-dense bodies (Fig. 6B C) compared                   The identity electron-dense organelles gly- <br /> with non-induced control (Fig. 6A). These round,                cosomes verified immuno-cytochemistry. TEM <br /> sometimes sausage-shaped (Fig. 6C, inset) bodies                sections WT, non-induced induced samples at <br /> morphologically similar glycosomes, organelle                 72 h labelled antibody glycosomal <br /> related peroxisomes (Opperdoes et al., 1984). Another            matrix enzyme marker, T. brucei glyceraldehyde phos- <br /> distinct feature treated cells increased            phate dehydrogenase (GAPDH) visualized with <br /> number flagella present 72 h sections                     10 nm protein-A gold particles (Fig. 7). In non- <br /> (Fig. 6B&#226;&#8364;&#8220;E, arrowheads). Even aber-             induced samples, gold particles exclusively localized <br /> rant number flagella associated main body            glycosomes confirming specificity antibody <br /> the parasite, appear normal 9 + 2                  reagent (Fig. 7A B). In contrast, induced <br /> arrangement microtubules axoneme                  samples pronounced labelling glycosomes with <br /> paraflagellar rod, suggesting structural organisa-         additional gold particles cytosol (Fig. 7C D, <br /> tion flagellum unaffected PTR1 depletion.              arrows). The matrix elongated electron-dense <br /> Some sections appear flagel-             structure Fig. 7D heavily stained confirming <br /> lar pocket (Fig. 6B), number autophagic             sausage-shaped structures (Fig. 6C) likely <br /> vacuoles. Lastly, structures evident sec-              glycosomes. <br /> tions, appeared internal non-membrane                   To verify increase number of <br /> bound flagellum (Fig. 6B plus inset, starred), phenotype          glycosomes following PTR1 depletion, immunofluores- <br /> previously observed knockdown VSG (Sheader                cence studies undertaken using anti-GAPDH. Stain- <br /> et al., 2005). Compared normal trypanosome                   ing GAPDH non-induced control punctate in <br /> (Fig. 6D, inset), tetracycline-induced trypanosomes            nature (Fig. 8A), pronounced diffuse <br /> an increase body size having sections               following induction tetracycline 48 h. Staining <br /> flagella detached body lacking undulat-            increased level covered entire <br />  <br />                                                               &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />                                                                                                              Essentiality pteridine reductase 1 663 <br />  <br />  <br />  <br />  <br /> Fig. 6. Morphology PTR1-depleted cells electron microscopy. <br /> A. TEM section non-induced controls. <br /> B C. TEM sections 72-h induced cells depicting increased number flagella glycosomes. <br /> D. SEM images 72-h induced cells, normal (top left) abnormal (bottom right) appearance compared non-induced <br /> control (inset). <br /> E. Equivalent DAPI-stained 72-h induced cell multiple flagella. <br /> Abbreviations used TEM sections: nucleus (N); nuclear membrane (NM); basal bodies (BB); kinetoplast (K); flagellar rod (FR); flagellar <br /> pocket (FP); axonemes (Ax black arrow heads); glycosomes (G); lysosomes (L); paraxial rod (PR); microtubules (MT); acidocalcisomes <br /> (Ac); autophagic vacuoles (AV) internal non-membrane bound flagellum (*). White arrow heads SEM images highlight flagella. Black and <br /> white bars represent 200 nm. <br />  <br />  <br />  <br /> body parasite 72 h. Some punctate staining                  48 h resulted partial diffuse staining cyto- <br /> also visible long structures radiating                plasm; however, unlike GAPDH, punctuate staining <br /> from main body multinucleated multiki-                  visible flagella 72 h. <br /> netoplast parasites (Fig. 8C). These structures con- <br /> firmed detached flagella staining antibody to <br />                                                                          Subcellular distribution PTR1 glycosomal markers <br /> the paraflagellar rod protein, ROD1 (Fig. 9). The increase <br /> in glycosomal staining <span id='am-471' about='xsp:pattern' typeof='owl:Thing'>pattern</span> illustrated GAPDH fol-               Cytosolic glycosomal fractions bloodstream form T. <br /> lowing RNAi expression confirmed using alterna-                   brucei prepared ultracentrifugation, following digi- <br /> tive glycosomal matrix marker, aldolase (ALD). Induction                 tonin treatment WT 48 h induced RNAi cells and <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  664 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br />  <br />  <br />  <br /> Fig. 7. Localization distribution GAPDH immuno-gold labelling. Thin-layer sections labelled anti-GAPDH stained with <br /> protein A gold particles examined TEM. WT (A), RNAi non-induced (B) induced (C&#226;&#8364;&#8220;D) 72 h. Abbreviations used: nucleus (N); <br /> glycosome (G) white asterisks alongside black dots represent 10 nm gold particles present glycosomes, white arrows depict <br /> particles outside glycosomes. Scale bar represents 200 nm. <br />  <br />  <br />  <br />  <br /> Fig. 8. The effect PTR1 depletion subcellular distribution glycosomal matrix enzyme, GAPDH immunofluorescence <br /> microscopy. Non-induced (A), induced 48 h (B) 72 h (C) RNAi cells labelled glycosomal matrix marker, GAPDH (green) with <br /> staining nuclear kinetoplast DNA DAPI (blue). MN, multinucleated, MK, multikinetoplastid. Scale bar represents 10 mm. <br />  <br />                                                                   &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />                                                                                                               Essentiality pteridine reductase 1 665 <br />  <br />  <br />  <br />  <br /> Fig. 9. Immunolocalisation aldolase paraflagellar rod marker, ROD1 RNAi depleted cells. Co-localization aldolase (glycosomal <br /> marker, green) ROD1 (paraflagellar rod marker, red) DAPI (blue) RNAi cells. Non-induced (A); induced 48 h (B); 72 h (C) <br /> RNAi cells. MN, multinucleated, MK, multikinetoplastid, scale bar represents 10 mm. <br />  <br />  <br /> analysed Western blotting antibodies specific                 samples possible lack material, the <br /> cytosolic glycosomal markers (Fig. 10). PTR1                     increased GAPDH observed 48 h induc- <br /> recovered exclusively cytosolic fraction               tion, supports mis-localization GAPDH the <br /> the cytosolic enzyme marker, enolase. Similar results                    cytosol illustrated immuno-gold labelling studies at <br /> were obtained procyclic forms (Fig. S3). Reduced                     72 h (Fig. 7). <br /> levels PTR1 evident cytosolic non-induced <br /> fraction RNAi cells compared WT, leaky                Discussion <br /> nature p2T7TiTAblue RNAi vector (Alibu et al., 2005). <br />                                                                          The gene knockout, RNAi knockdown rescue studies <br /> Following RNAi induction 48 h, PTR1 limit <br />                                                                          reported provide strong evidence PTR1 is <br /> of detection, enolase PEX13, glycosomal <br />                                                                          essential blood-stream form African <br /> membrane-bound protein, unchanged. Densitom- <br />                                                                          trypanosome. Loss PTR1 RNAi cytocidal rather <br /> etry band stained glycosomal matrix enzyme <br />                                                                          cytostatic, distinct advantage drug <br /> GAPDH indicated pellet fraction unchanged <br />                                                                          discovery perspective. This lethal RNAi phenotype be <br /> whereas the cytosol increased approxi- <br />                                                                          rescued expression functionally active L. major <br /> mately twofold. Although analysis 72 h induced <br />                                                                          PTR1, supplementation tetrahydrobiopterin. <br />                                                                          PTR1 levels markedly reduced absence <br />                                                                          inducer poor regulation pLew82 vector. <br />                                                                          While discernable effect growth rich <br />                                                                          medium vitro, virulence PTR1 RNAi T. brucei <br />                                                                          considerably attenuated mice. Further loss viru- <br />                                                                          lence evident RNAi induced, some <br />                                                                          mice succumbed infection. This likely to <br />                                                                          instability RNAi machinery previously <br />                                                                          reported (Chen et al., 2003). However, supplemen- <br />                                                                          tation 10 mM tetrahydrobiopterin able rescue <br />                                                                          trypanocidal effect vitro, definitively <br />                                                                          exclude possibility steady-state levels tet- <br />                                                                          rahydrobiopterin present animal host plasma <br /> Fig. 10. The effect PTR1 depletion subcellular                 (~0.1 mM) contributing survival (Fukushima and <br /> distribution glycolytic enzymes. Digitonin fractionation intact <br /> WT RNAi cells grown 48 h (in absence &#226;&#8364;&#732;&#226;&#8364;&#8220;&#226;&#8364;&#8482; presence        Nixon, 1980; Yoshida et al., 2000). The fact BH4 is <br /> &#226;&#8364;&#732;+&#226;&#8364;&#8482; tetracycline) incubated 150 mg ml-1 digitonin    extremely unstable culture medium repeated <br /> processed described Material Methods. The release           daily addition BH4 toxic T. brucei <br /> PTR1, enolase, PEX13 GAPDH digitonin-treated cells <br /> was determined supernatant (S) pellet (P) fractions            explain failure generate double knockout <br /> Western blot.                                                            line using BH4 nutritional rescue. Thus, ultimate proof <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  666 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br /> that PTR1 suitable drug target requires               resulted smaller numbers larger glycosomes (Baner- <br /> chemical validation using potent specific drug-like               jee et al., 2005). However, studies reported <br /> inhibitors PTR1 appropriate pharmacological                   defects cytokinesis observed here. <br /> properties. Unfortunately, currently available inhibitors            The discovery TbPTR1 present the <br /> do meet specifications (Cavazzuti et al., 2008;             cytosol bloodstream (Fig. 10) procyclic forms <br /> Mpamhanga et al., 2009; Shanks et al., 2010). Nonethe-                (Fig. S3) refutes predicted glycosomal location for <br /> less, combined inhibition dihydrofolate reductase              PTR1, based PST1 consensus sequence -VHA at <br /> PTR1 remains attractive chemotherapeutic strategy                  C-terminus (Opperdoes Szikora, 2006). This is <br /> (Hardy et al., 1997; Cavazzuti et al., 2008; Tulloch et al.,          consistent failure detect PTR1 proteomic <br /> 2010).                                                                analysis purified T. brucei glycosomes (Vertommen <br />    Our morphological data illustrate knockdown                et al., 2008) agrees cytosolic location a <br /> PTR1 results cells unable divide normally,             GFP-PTR1 chimera L. donovani (Kumar et al., 2007). <br /> although undergo nuclear division kine-            Likewise, trypanothione reductase trypan- <br /> toplast segregation. Formation multiflagellated para-              othione peroxidase T. brucei contain putative <br /> sites reported number RNAi                glycosomal targeting sequences, clearly <br /> studies dissecting organelle biogenesis including: deple-             cytosolic (Smith et al., 1991) located in <br /> tion trypanin, component dynein regulatory                cytosol mitochondria (Schlecker et al., 2005). <br /> complex flagellum (Ralston Hill, 2006); deple-             This underlines need experimental verification of <br /> tion centrin1, component associated basal               silico bioinformatic predictions (Wanders and <br /> bodies responsible segregation linked                  Waterham, 2006). <br /> organelles: flagellum, kinetoplasts Golgi (Selva-                    PTR1 clearly pleiotropic effects cytokinesis, <br /> pandiyan et al., 2007); depletion aurora-like kinase           flagellar morphology glycosome biogenesis. The <br /> AUK1, chromosome passenger protein (Li Wang,                    challenging question underlying biochemical <br /> 2006; Jetton et al., 2009); depletion CAP5.5 result-           mechanism? Of known functions PTR1, the <br /> ing defects microtubule organization (Olego-                    maintenance biopterin tetrahydro-form seems <br /> Fernandez et al., 2009). However, studies               likely salvage folate dihydrofolate, <br /> have observed glycosomal abnormalities reported                   growth phenotype rescued supple- <br /> here. Further work required determine             mentation H4B high- low-folate media containing <br /> RNAi mutants cytokinesis defects similar              thymidine. Since functions pterins remain be <br /> glycosomal abnormalities.                                             elucidated T. brucei speculate these <br />    Knockdown PTR1 affects glycosomal numbers                  functions be. For example, ether lipid <br /> and morphology, judged TEM. PTR1 knock-                   biosynthetic pathway present mammalian peroxi- <br /> down causes partial mislocalisation cytosol            somes cells (Kaufman et al., 1990) trypanosomatid <br /> the glycosomal matrix enzymes, GAPDH aldolase,                 glycosomes (Lux et al., 2000; Parsons et al., 2001; <br /> seen immunofluorescence digitonin fraction-                Michels et al., 2006). To date, enzymes of <br /> ation experiments. In view, mislocalization              pathway identified trypanosomatids by <br /> due defective import glycosome           fractionation, bioinformatic proteomic based analysis <br /> loss integrity glycosomal membrane. However,                (Heise Opperdoes, 1997; Opperdoes Szikora, <br /> similar effects observed studies functional roles           2006; Vertommen et al., 2008), are <br /> of peroxins attributed defective import. Per-            known pterin-dependent. However, BH4 involved <br /> oxins (PEX) large family peroxisomal proteins                ether lipid catabolism mammalian cells, it <br /> which involved glycosomal biogenesis                   serves essential cofactor cleavage ether <br /> import newly synthesized proteins cytosol                 lipids glyceryl ether monooxygenase (EC 1.14.16.5) <br /> (Parsons et al., 2001). Cellular knockdown RNA inter-              located microsomal compartment (Watschinger <br /> ference PEX 13 (Furuya et al., 2002; Verplaetse et al.,            et al., 2009). The ultimate products ether lipid cleavage <br /> 2009), GIM5 (a PEX11-related protein) (Furuya et al.,                 glycerol fatty alcohol. Possibly, fatty alco- <br /> 2002; Moyersoen et al., 2003; Voncken et al., 2003; Ver-              hols serve subsequent ether lipid synthesis in <br /> plaetse et al., 2009), PEX14 (Moyersoen et al., 2003),                glycosome. However, fact oxidative cleavage <br /> PEX19 (Banerjee et al., 2005); PEX6, PEX10                    ether lipids L. donovani dependent <br /> PEX12 (Krazy Michels, 2006) resulted                   NADPH tetrahydrobiopterin (Ma et al., <br /> partial mislocalization glycosomal matrix enzymes               1996) tends argue hypothesis. Tetrahydro- <br /> the cytosol. Overexpression PEX11 led increased              biopterin plays role defence oxidative <br /> number glycosomes elongated clus-                   nitrosative stress mammalian cells (Mogi et al., <br /> tered (Lorenz et al., 1998), knockdown PEX19               1999; Ozkor Quyyumi, 2008) recent studies in <br />  <br />                                                                 &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />                                                                                                       Essentiality pteridine reductase 1 667 <br />  <br /> PTR1 knockout overexpressing lines suggest                   Western blot analysis <br /> similar role Leishmania spp. (Moreira et al., 2009; Nare <br />                                                                    The WT, RNAi (0, 24 48 h) oeRNAi (48 h) cells were <br /> et al., 2009). <br />                                                                    centrifuged 20 000 g 5 min 4&#194;&#176;C. The cell pellets <br />    In conclusion, data strongly suggest PTR1           (1 &#194;&#165; 106 parasites sample) resuspended SDS <br /> essential blood stream T. brucei growth sur-           Laemmli buffer, boiled 5 min micro-centrifuged as <br /> vival vitro animal host. The phenotypic abnor-       above. The supernatants separated SDS- <br /> malities uncovered investigation suggest                 PAGE subsequently transferred nitrocellulose for <br /> potential role PTR1 biogenesis glycosome         immunoblotting previously described (Sienkiewicz et al., <br /> and flagellum. Further studies underway             2008). The immunoblot RNAi set sequentially <br />                                                                    probed polyclonal antisera raised T. brucei <br /> laboratory investigate possibilities. <br />                                                                    PTR1 (1:500 dilution) BiP (1:10 000), conjunction with <br />                                                                    secondary rabbit anti-rat HRP-conjugated antibody <br />                                                                    (1:5 000, Dako). The oeRNAi samples sequentially <br /> Experimental procedures                                            probed T. brucei PTR1 antisera L. major PTR1 <br />                                                                    (1:10 000), conjunction secondary rabbit anti-rat and <br /> Trypanosome culture <br />                                                                    goat anti-rabbit HRP-conjugated antibodies (1:5000 and <br /> Trypanosoma brucei bloodstream form &#226;&#8364;&#732;single marker&#226;&#8364;&#8482; S427           1:10 000 respectively) immunoblots visualized with <br /> (T7RPOL TETR NEO) transfected cells cultured           ECL plus (enhanced chemiluminescence) from <br /> previously described (Wirtz et al., 1999) (Alibu et al.,       GE Healthcare. <br /> 2005). Folate deficient media (FDM) growth conditions <br /> used study previously described (Sienkiewicz <br /> et al., 2008). Tetrahydrobiopterin purchased B.           Enzyme assays <br /> Shircks Laboratories (Jona, Switzerland) 10 mM stock           Lysates T. brucei prepared previously described <br /> was prepared degassed 0.1 M HCl. <br />                                                                    (Vickers Fairlamb, 2004). To ensure adequate extraction <br />                                                                    parasites, trypanothione reductase activity measured <br />                                                                    clarified lysates previously described (Jockers-Scherubl <br /> Cloning generation transgenic cell lines                    et al., 1989). Assays PTR1 activity clarified lysates were <br /> All constructs sequenced prepared elec-          carried 22&#194;&#176;C 50 mM HEPES (pH 7.4), containing <br /> troporation using QIAprep Miniprep Plasmid Kit (Qiagen).           0.1% (v/v) triton X-100, adjusted ionic strength of <br /> DNA constructs prepared electroporation trypa-       100 mM KCl. Lysates preincubated 100 mM <br /> nosomes cloned procedures performed pre-           NADPH cofactor 2 min reactions initiated the <br /> viously described (Wirtz et al., 1999; Sienkiewicz et al.,         addition 25 nM H2B, final volume 200 ml. Enzymatic <br /> 2008). Primers used study generate RNAi         reactions incubated 1 min, aliquots <br /> overexpressor constructs (Table S1) based               (100 ml) removed oxidized iodine alka- <br /> GeneDB sequences T. brucei PTR1 (Tb927.8.2210, 927             line conditions analysed HPLC previously <br /> strain) L. major PTR1 (LmjF23.0270, Friedlin strain). For      described (Shanks et al., 2010). Protein measured using <br /> the disruption PTR1 function, 403 bp region (nucleotide       Coomassie blue using bovine serum albumin standard <br /> position 399&#226;&#8364;&#8220;801; http://trypanofan.path.cam.ac.uk/software/       (Bradford, 1976). <br /> RNAit.html) directly ligated p2T7TiTAblue vector <br /> (http://trypanofan.path.cam.ac.uk/trypanofan/vector/; gen- <br />                                                                    Morphological analysis <br /> erous gift David Horn), linearized digestion NotI <br /> and transfected electroporation generate RNAi cells          RNAi cells (grown presence absence tetracy- <br /> under hygromycin selection (4 mg ml-1). An overexpressor           cline) fixed methanol 4% (v/v) paraformaldehyde <br /> construct (pLew82), containing L. major PTR1 ORF           stained Giemsa 4&#226;&#8364;&#178;,6-diamidino-2- <br /> also generation overexpressor WT (oeWT)             phenylindole (Slowfade Gold antifade reagent DAPI, <br /> under phleomycin selection (2.5 mg ml-1). The oeWT cells gen-      Invitrogen). Images captured Zeiss Axiovert 200 M <br /> erated used reintroduction p2T7TiTAblue        fluorescence light microscope using Zeiss AxioVision <br /> RNAi construct generate oeRNAi cells. All tetracycline          Software. Approximately 300 parasites population were <br /> induction experiments initiated 1 &#194;&#165; 104 cells ml-1     assessed changes N:K ratio data presented the <br /> tetracycline added daily 1 mg ml-1.                             mean independent knockdown experiments. For elec- <br />                                                                    tron microscopy, cells fixed 24 h 2% (v/v) glutaral- <br />                                                                    dehyde 4% (v/v) paraformaldehyde 0.2 M PIPES, pH <br /> DNA analysis                                                       7.2 prepared SEM TEM previously <br />                                                                    described (Sienkiewicz et al., 2008). <br /> The WT RNAi genomic DNA (5 mg) digested the <br /> restriction enzyme StuI blots subsequently probed <br /> with TbPTR1 ORF described previously (Sienkiewicz               Immuno-gold labelling TEM sections <br /> et al., 2008). Southern blot analysis used confirm the <br /> successful integration selectable gene markers         For immunoelectron microscopy labelling staining <br /> WT cells (see Supporting information ).                            procedure carried essentially described (Sandi- <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  668 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br /> lands et al., 2004; Sienkiewicz et al., 2008). Briefly, samples           Research Institute (NMRI) mice (5 group) infected <br /> previously embedded Durcupan resin etched 1%                 single intraperitoneal injection 105 parasites 0.2 ml <br /> (v/v) periodic acid osmium removed 2% (w/v)                    glucose saline previously described (Sienkiewicz et al., <br /> sodium periodate. The sections probed anti-                2008). For RNAi oeRNAi cells, single inoculum of <br /> GAPDH (1: 50 dilution) antibody subsequently incubated                non-induced cells infected sets mice one <br /> with Protein A labelled 10 nm gold particles (1:50 dilu-             group given 2.5 mg ml-1 doxycycline drinking <br /> tion, BB International) visualize primary antibody. The            water (starting week prior infection continuing <br /> sections stained 3% (v/v) aqueous uranyl acetate                30 day period). Animals fed ad libitum on <br /> and Reynold&#226;&#8364;&#8482;s lead citrate prior examination JEOl-              standard chow (Diet 3, SAS, Edinburgh). Parasitaemia levels <br /> 1200 EX TEM.                                                              monitored 30 day experiment (Sienk- <br />                                                                           iewicz et al., 2008). All animal experiments undertaken were <br />                                                                           carried following local ethical review UK regu- <br /> Immunofluorescence                                                        latory licensing accordance European Communi- <br />                                                                           ties Council Directive (86/609/EEC). <br /> Cells fixed 4% (v/v) paraformaldehyde poly- <br /> L-lysine coated chamber slides probed antisera <br /> raised T. brucei GAPDH (rabbit antiserum, 1:2500),                Acknowledgements <br /> ALD (rabbit antiserum, 1:6000) ROD1 (monoclonal anti- <br /> serum, neat), generous gifts Paul Michels Keith                  We like thank Professor Steve Beverley (Washing- <br /> Gull, previously described (Woods et al., 1989; Verplaetse             ton University School Medicine) Professor Paul <br /> et al., 2009). Combination secondary Alexafluor 488                Michels (Universit&#195;&#169; Catholique Louvain), helpful dis- <br /> 555 conjugated ant-rabbit anti-mouse immunoglobulins                   cussions, useful advice encouragement; Professor <br /> were used (both 1:800 dilution, Molecular Probes) slides              George Cross Dr Simone Leal (Rockefeller University, <br /> were counter-stained DAPI prior analysis. Images                  New York, USA) provision transgenic cell lines; <br /> were captured using FITC, Texas Red DAPI filters                   Professor David Horn (London School Hygiene Tropi- <br /> previously described. Property parameters set                 cal Medicine) p2T7TiTAblue vector; Professor Steve <br /> AxioVision microscope software optimize intensity               Beverley, Professor James Bangs (University Wisconsin), <br /> the fluorescent stains standardized non-induced               Professor Paul Michels Professor Keith Gull (University <br /> controls values retained images                    Oxford) kind gifts antisera helpful insights <br /> captured. Images shown representative indepen-               trypanosome biology; Dr Lucia G&#195;&#188;ther helpful <br /> dent experiments.                                                         discussions reagents; Dr Susan Wyllie critical analy- <br />                                                                           sis manuscript; Mr Martin Keirens CHIPs <br />                                                                           facility help advice electron microscopy. This <br /> Separation cytosolic glycosomal rich proteins                   study supported funding Wellcome Trust <br /> digitonin permeabilization                                                (WT079838 WT WT083481). <br />  <br /> Digitonin permeabilization experiments undertaken to <br /> separate cytosolic glycosomal rich proteins WT               References <br /> RNAi cells (grown absence presence tetracy- <br /> cline 48 h), previously described (Voncken et al.,                 Alibu, V.P., Storm, L., Haile, S., Clayton, C., Horn, D. <br /> 2003). Briefly, live cells washed STEN (250 mM                  (2005) A doubly inducible RNA interference and <br /> sucrose, 25 mM Tri-HCl, 1 mM EDTA, 150 mM NaCl, pH 7.4),                     rapid RNAi plasmid construction Trypanosoma brucei. <br /> pelleted resuspended STEN containing 150 mg ml-1                      Mol Biochem Parasitol 139: 75&#226;&#8364;&#8220;82. <br /> digitonin (at final concentration 5 &#194;&#165; 108 cells ml-1)         Armarego, W.L.F., Randles, D., Taguchi, H. (1983) Km <br /> subsequently incubated 1 h ice. The digitonin treated                kcat values [6,6,7,7-2H]7,8(6H)-dihydropterin and <br /> cells fractionated centrifugation (2 min,                      2,6-diamino-5-iminopyrimidin-4-one dihydropteridine <br /> 20 000 g, 4&#194;&#176;C) resulting enriched cytosolic (s, super-             reductase. Biochem J 211: 357&#226;&#8364;&#8220;361. <br /> natant) glycosomal (p, pellet) fractions. Approximately               Banerjee, S.K., Kessler, P.S., Saveria, T., Parsons, M. <br /> 5 &#194;&#165; 106 fractionated parasites processed Western                   (2005) Identification trypanosomatid PEX19: functional <br /> blot analysis sequentially probed following anti-              characterization reveals impact cell growth glyco- <br /> bodies raised T. brucei PTR1 (1:500), rabbit antisera               size number. Mol Biochem Parasitol 142: 47&#226;&#8364;&#8220;55. <br /> raised PEX13 (1:20 000), enolase (1:100 000)                  Bello, A.R., Nare, B., Freedman, D., Hardy, L., Beverley, <br /> GAPDH (1:100 000). Blots subsequently incubated                   S.M. (1994) PTR1: reductase mediating salvage oxi- <br /> secondary anti-rat (1:5000 dilution) anti-rabbit HRP-                   dized pteridines methotrexate resistance proto- <br /> conjugated antiserum (1:15 000) visualized previously                zoan parasite Leishmania major. Proc Natl Acad Sci USA <br /> described.                                                                  91: 11442&#226;&#8364;&#8220;11446. <br />                                                                           Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., <br />                                                                             Renauld, H., Bartholomeu, D.C., et al. (2005) The Genome <br /> In vivo studies                                                             African Trypanosome Trypanosoma brucei. Science <br />                                                                             309: 416&#226;&#8364;&#8220;422. <br /> All cell lines (WT, RNAi, oeRNAi) cultured 24 h           Bradford, M.M. (1976) A rapid sensitive method the <br /> absence selectable drugs female National Medical                  quantitation microgram quantities protein utilizing the <br />  <br />                                                                     &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />                                                                                                       Essentiality pteridine reductase 1 669 <br />  <br />   principle protein-dye binding. Anal Biochem 72: 248&#226;&#8364;&#8220;             cruzi: catalytic properties enzyme inhibition <br />   254.                                                                studies trypanocidal compounds. Eur J Biochem 180: <br /> Callahan, H.L., Beverley, S.M. (1992) A member             267&#226;&#8364;&#8220;272. <br />   aldoketo reductase family confers methotrexate resistance        Kaufman, S. (1963) The structure phenylalanine- <br />   Leishmania. J Biol Chem 267: 24165&#226;&#8364;&#8220;24168.                        hydroxylation cofactor. Proc Natl Acad Sci USA 50: 1085&#226;&#8364;&#8220; <br /> Cavazzuti, A., Paglietti, G., Hunter, W.N., Gamarro, F., Piras,       1093. <br />   S., Loriga, M., et al. (2008) Discovery potent pteridine      Kaufman, S., Pollock, R.J., Summer, G.K., Das, A.K., and <br />   reductase inhibitors guide antiparasite drug                     Hajra, A.K. (1990) Dependence alkyl glycol-ether <br />   development. Proc Natl Acad Sci USA 105: 1448&#226;&#8364;&#8220;1453.                 monooxygenase activity tetrahydropterins. Biochim <br /> Chen, Y.L., Hung, C.H., Burderer, T., Lee, G.S.M. (2003)          Biophys Acta 1040: 19&#226;&#8364;&#8220;27. <br />   Development RNA interference revertants Trypano-           Kidder, G.W., Dutta, B.N. (1958) The growth nutrition <br />   soma brucei cell lines generated double stranded             Crithidia fasciulata. J Gen Microbiol 18: 621&#226;&#8364;&#8220;638. <br />   RNA expression construct driven opposing                  Krazy, H., Michels, P.A.M. (2006) Identification char- <br />   promoters. Mol Biochem Parasitol 126: 275&#226;&#8364;&#8220;279.                      acterization peroxins &#226;&#8364;&#8220; PEX6, PEX10 PEX12 <br /> Cruz, A.K., Titus, R., Beverley, S.M. (1993) Plasticity        &#226;&#8364;&#8220; involved glycosome biogenesis Trypanosoma <br />   chromosome number testing essential genes                 brucei. Biochim Biophys Acta 1763: 6&#226;&#8364;&#8220;17. <br />   Leishmania targeting. Proc Natl Acad Sci USA 90:              Kumar, P., Sundar, S., Singh, N. (2007) Degradation of <br />   1599&#226;&#8364;&#8220;1603.                                                          pteridine reductase 1 (PTR1) enzyme growth phase <br /> Cunningham, M.L., Beverley, S.M. (2001) Pteridine                 protozoan parasite Leishmania donovani. Exp Para- <br />   salvage Leishmania infectious cycle: impli-          sitol 116: 182&#226;&#8364;&#8220;189. <br />   cations antifolate chemotherapy. Mol Biochem Parasitol       Kundig, C., Haimeur, A., Legare, D., Papadopoulou, B., and <br />   113: 199&#226;&#8364;&#8220;213.                                                       Ouellette, M. (1999) Increased transport pteridines com- <br /> Cunningham, M.L., Titus, R.G., Turco, S.J., Beverley,             pensates mutations high affinity folate transporter <br />   S.M. (2001) Regulation differentiation infective          contributes methotrexate resistance proto- <br />   stage protozoan parasite Leishmania major                 zoan parasite Leishmania tarentolae. EMBO J 18: 2342&#226;&#8364;&#8220; <br />   tetrahydrobiopterin. Science 292: 285&#226;&#8364;&#8220;287.                          2351. <br /> Dawson, A., Gibellini, F., Sienkiewicz, N., Tulloch, L.B., Fyfe,   Lemley, C., Yan, S.F., Dole, V.S., Madhubala, R., Cunning- <br />   P.K., McLuskey, K., et al. (2006) Structure reactivity       ham, M.L., Beverley, S.M., et al. (1999) The Leishmania <br />   Trypanosoma brucei pteridine reductase: inhibition           donovani LD1 locus gene ORFG encodes biopterin <br />   archetypal antifolate methotrexate. Mol Microbiol 61:               transporter (BT1). Mol Biochem Parasitol 104: 93&#226;&#8364;&#8220;105. <br />   1457&#226;&#8364;&#8220;1468.                                                       Li, Z.Y., Wang, C.C. (2006) Changing roles aurora-B <br /> Fukushima, T., Nixon, J.C. (1980) Analysis reduced             kinase life cycle stages Trypanosoma brucei. <br />   forms biopterin biological tissues fluids. Anal           Eukaryotic Cell 5: 1026&#226;&#8364;&#8220;1035. <br />   Biochem 102: 176&#226;&#8364;&#8220;188.                                            Lorenz, P., Maier, A.G., Baumgart, E., Erdmann, R., and <br /> Furuya, T., Kessler, P., Jardim, A., Schnaufer, A., Crudder,          Clayton, C. (1998) Elongation clustering glyco- <br />   C., Parsons, M. (2002) Glucose toxic glycosome-           somes Trypanosoma brucei overexpressing glyco- <br />   deficient trypanosomes. Proc Natl Acad Sci USA 99:                  somal Pex11p. EMBO J 17: 3542&#226;&#8364;&#8220;3555. <br />   14177&#226;&#8364;&#8220;14182.                                                     Luba, J., Nare, B., Liang, P.H., Anderson, K.S., Beverley, <br /> Gourley, D.G., Schuttelkopf, A.W., Leonard, G.A., Luba, J.,           S.M., Hardy, L.W. (1998) Leishmania major pteridine <br />   Hardy, L.W., Beverley, S.M., Hunter, W.N. (2001) Pte-           reductase 1 belongs short chain dehydrogenase <br />   ridine reductase mechanism correlates pterin metabolism             family: stereochemical kinetic evidence. Biochemistry <br />   drug resistance trypanosomatid parasites. Nat               37: 4093&#226;&#8364;&#8220;4104. <br />   Struct Biol 8: 521&#226;&#8364;&#8220;525.                                          Lux, H., Heise, N., Klenner, T., Hart, D., Opperdoes, F.R. <br /> Hardy, L.W., Matthews, W., Nare, B., Beverley, S.M.               (2000) Ether-lipid (alkyl-phospholipid) metabolism and <br />   (1997) Biochemical genetic tests inhibitors Leish-       mechanism action ether-lipid analogues in <br />   mania pteridine pathways. Exp Parasitol 87: 157&#226;&#8364;&#8220;169.                Leishmania. Mol Biochem Parasitol 111: 1&#226;&#8364;&#8220;14. <br /> Heise, N., Opperdoes, F.R. (1997) The dihydroxyaceto-          Lye, L.F., Cunningham, M.L., Beverley, S.M. (2002) <br />   nephosphate pathway biosynthesis ether lipids             Characterization quinonoid-dihydropteridine reductase <br />   Leishmania mexicana promastigotes. Mol Biochem Para-                (QDPR) lower eukaryote Leishmania major. J Biol <br />   sitol 89: 61&#226;&#8364;&#8220;72.                                                    Chem 277: 38245&#226;&#8364;&#8220;38253. <br /> Ivens, A.C., Peacock, C.S., Worthey, E.A., Murphy, L.,             Ma, D.Q., Beverley, S.M., Turco, S.J. (1996) Leishmania <br />   Aggarwal, G., Berriman, M., et al. (2005) The genome             donovani possess NADPH-dependent alkylglycerol <br />   kinetoplastid parasite, Leishmania major. Science 309:          cleavage enzyme. Biochem Biophys Res Commun 227: <br />   436&#226;&#8364;&#8220;442.                                                            885&#226;&#8364;&#8220;889. <br /> Jetton, N., Rothberg, K.G., Hubbard, J.G., Wise, J., Li, Y.,       Michels, P.A.M., Bringaud, F., Herman, M., Hannaert, <br />   Ball, H.L., Ruben, L. (2009) The cell cycle thera-         V. (2006) Metabolic functions glycosornes in <br />   peutic target Trypanosoma brucei: hesperadin                trypanosomatids. Biochim Biophys Acta 1763: 1463&#226;&#8364;&#8220;1477. <br />   inhibits Aurora kinase-1 blocks mitotic progression       Mogi, M., Kinpara, K., Kondo, A., Togari, A. (1999) <br />   bloodstream forms. Mol Microbiol 72: 442&#226;&#8364;&#8220;458.                       Involvement nitric oxide biopterin proinflammatory <br /> Jockers-Scherubl, M.C., Schirmer, R.H., Krauth-Siegel,            cytokine-induced apoptotic cell death mouse osteoblas- <br />   R.L. (1989) Trypanothione reductase Trypanosoma                tic cell line MC3T3-E1. Biochem Pharmacol 58: 649&#226;&#8364;&#8220;654. <br />  <br /> &#194;&#169; 2010 Blackwell Publishing Ltd, Molecular Microbiology, 77, 658&#226;&#8364;&#8220;671 <br />  670 N. Sienkiewicz, H. B. Ong A. H. Fairlamb &#228;&#352;? <br />  <br /> Moreira, W., Leblanc, E., Ouellette, M. (2009) The role          Schlecker, T., Schmidt, A., Dirdjaja, N., Voncken, F., Clayton, <br />   reduced pterins resistance reactive oxygen nitro-             C., Krauth-Siegel, R.L. (2005) Substrate specificity, <br />   gen intermediates protozoan parasite Leishmania.                 localization, essential role glutathione <br />   Free Radic Biol Med 46: 367&#226;&#8364;&#8220;375.                                        peroxidase-type tryparedoxin peroxidases Trypanosoma <br /> Moyersoen, J., Choe, J., Kumar, A., Voncken, F.G.J., Hol,                 brucei. J Biol Chem 280: 14385&#226;&#8364;&#8220;14394. <br />   W.G.J., Michels, P.A.M. (2003) Characterization Try-           Schmidt, T.S., Alp, N.J. (2007) Mechanisms role <br />   panosoma brucei PEX14 role import gly-                tetrahydrobiopterin endothelial function vascular <br />   cosomal matrix proteins. Eur J Biochem 270: 2059&#226;&#8364;&#8220;2067.                  disease. Clin Sci 113: 47&#226;&#8364;&#8220;63. <br /> Mpamhanga, C.P., Spinks, D., Tulloch, L.B., Shanks, E.J.,               Schormann, N., Pal, B., Senkovich, O., Carson, M., Howard, <br />   Robinson, D.A., Collie, I.T., et al. (2009) One scaffold,               A., Smith, C., et al. (2005) Crystal structure Trypano- <br />   binding modes: novel selective pteridine reduc-               soma cruzi pteridine reductase 2 complex sub- <br />   tase 1 Inhibitors derived fragment hits discovered              strate inhibitor. J Struct Biol 152: 64&#226;&#8364;&#8220;75. <br />   virtual screening. J Med Chem 52: 4454&#226;&#8364;&#8220;4465.                          Schuttelkopf, A.W., Hardy, L.W., Beverley, S.M., Hunter, <br /> Nare, B., Luba, J., Hardy, L.W., Beverley, S.M. (1997)                W.N. (2005) Structures Leishmania major pteridine <br />   New approaches Leishmania chemotherapy: pteridine                    reductase complexes reveal active site features impor- <br />   reductase 1 (PTR1) target modulator antifolate              tant ligand binding guide inhibitor design. J Mol <br />   sensitivity. Parasitol 114: S101&#226;&#8364;&#8220;S110.                                  Biol 352: 105&#226;&#8364;&#8220;116. <br /> Nare, B., Garraway, L.A., Vickers, T.J., Beverley, S.M.             Selvapandiyan, A., Kumar, P., Morris, J.C., Salisbury, J.L., <br />   (2009) PTR1-dependent synthesis tetrahydrobiopterin                  Wang, C.C., Nakhasi, H.L. (2007) Centrin1 required <br />   contributes oxidant susceptibility trypanosomatid             organelle segregation cytokinesis Trypanosoma <br />   protozoan parasite Leishmania major. Curr Genet 55: 287&#226;&#8364;&#8220;                brucei. Mol Biol Cell 18: 3290&#226;&#8364;&#8220;3301. <br />   299.                                                                  Shanks, E.J., Ong, H.B., Robinson, D.A., Thompson, S., <br /> Nichol, C.A., Lee, C.L., Edelstein, M.P., Chao, J.Y., Duch,           Sienkiewicz, N., Fairlamb, A.H., Frearson, J.A. (2010) <br />   D.S. (1983) Biosynthesis tetrahydrobiopterin novo              Development validation cytochrome c coupled <br />   salvage pathways adrenal-medulla extracts,                       assay pteridine reductase 1 dihydrofolate <br />   mammalian-cell cultures, rat-brain vivo. Proc Natl               reductase. Anal Biochem 396: 194&#226;&#8364;&#8220;203. <br />   Acad Sci USA 80: 1546&#226;&#8364;&#8220;1550.                                           Sheader, K., Vaughan, S., Minchin, J., Hughes, K., Gull, K., <br /> Olego-Fernandez, S., Vaughan, S., Shaw, M.K., Gull, K.,               Rudenko, G. (2005) Variant surface glycoprotein RNA <br />   Ginger, M.L. (2009) Cell morphogenesis Trypanosoma                   interference triggers precytokinesis cell cycle arrest in <br />   brucei requires paralogous, differentially expressed                African trypanosomes. Proc Natl Acad Sci USA 102: 8716&#226;&#8364;&#8220; <br />   calpain-related proteins CAP5.5 CAP5.5V. Protist 160:               8721. <br />   576&#226;&#8364;&#8220;590.                                                              Sienkiewicz, N., Jaroslawski, S., Wyllie, S., Fairlamb, <br /> Opperdoes, F.R., Szikora, J.P. (2006) In silico prediction            A.H. (2008) Chemical genetic validation dihydro- <br />   glycosomal enzymes Leishmania major                       folate reductase-thymidylate synthase drug target in <br />   trypanosomes. Mol Biochem Parasitol 147: 193&#226;&#8364;&#8220;206.                       African trypanosomes. Mol Microbiol 69: 520&#226;&#8364;&#8220;533. <br /> Opperdoes, F.R., Baudhuin, P., Coppens, I., Roe, C.,                 Smith, K., Opperdoes, F.R., Fairlamb, A.H. (1991) Sub- <br />   Edwards, S.W., Weijers, P.J., Misset, O. (1984) Puri-               cellular distribution trypanothione reductase blood- <br />   fication, morphometric analysis, characterization            stream procyclic forms Trypanosoma brucei. Mol <br />   glycosomes (microbodies) protozoan hemoflagellate                Biochem Parasitol 48: 109&#226;&#8364;&#8220;112. <br />   Trypanosoma brucei. J Cell Biol 98: 1178&#226;&#8364;&#8220;1184.                        Thony, B., Auerbach, G., Blau, N. (2000) Tetrahydrobiop- <br /> Ouellette, M., Drummelsmith, J., El Fadili, A., Kundig, C.,               terin biosynthesis, regeneration functions. Biochem J <br />   Richard, D., Roy, G. (2002) Pterin transport                    347: 1&#226;&#8364;&#8220;16. <br />   metabolism Leishmania related trypanosomatid                   Tulloch, L.B., Martini, V.P., Iulek, J., Huggan, J.K., Lee, J.H., <br />   parasites. Int J Parasitol 32: 385&#226;&#8364;&#8220;398.                                 Gibson, C.L., et al. (2010) Structure-based design pte- <br /> Ozkor, M.A., Quyyumi, A.A. (2008) Tetrahydrobiopterin.                ridine reductase inhibitors targeting African sleeping sick- <br />   Curr Hypertens Rep 10: 58&#226;&#8364;&#8220;64.                                 <br /> </body></html>